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Abstract
Background: Bombyx mori silk fibroin is a biomacromolecule that allows the assembly of scaffolds
for tissue engineering and regeneration purposes due to its cellular adhesiveness, high biocompat-
ibility and low immunogenicity. Earlier work showed that two types of 3D silk fibroin nonwovens
(3D-SFnws) implanted into mouse subcutaneous tissue were promptly vascularized via undefined
molecular mechanisms. The present study used nontumorigenic adult human dermal fibroblasts
(HDFs) adhering to a third type of 3D-SFnws to assess whether HDFs release exosomes whose
contents promote neoangiogenesis.
Methods: Electron microscopy imaging and physical tests defined the features of the novel
carded/hydroentangled 3D-SFnws. HDFs were cultured on 3D-SFnws and polystyrene plates in
an exosome-depleted medium. DNA amounts and D-glucose consumption revealed the growth
and metabolic activities of HDFs on 3D-SFnws. CD9-expressing total exosome fractions were from
conditionedmedia of 3D-SFnws and 2Dpolystyrene plates HDF cultures. Angiogenic growth factors
(AGFs) in equal amounts of the two groups of exosomal proteins were analysed via double-
antibody arrays. A tube formation assay using human dermal microvascular endothelial cells
(HDMVECs) was used to evaluate the exosomes’ angiogenic power.
Results: The novel features of the 3D-SFnwsmet the biomechanical requirements typical of human
soft tissues. By experimental day 15, 3D-SFnws-adhering HDFs had increased 4.5-fold in numbers
and metabolized 5.4-fold more D-glucose than at day 3 in vitro. Compared to polystyrene-stuck
HDFs, exosomes from 3D-SFnws-adhering HDFs carried significantly higher amounts of AGFs,
such as interleukin (IL)-1α, IL-4 and IL-8; angiopoietin-1 and angiopoietin-2; angiopoietin-1 receptor
(or Tie-2); growth-regulated oncogene (GRO)-α, GRO-β and GRO-γ ; matrix metalloproteinase-1;
tissue inhibitor metalloproteinase-1; and urokinase-type plasminogen activator surface receptor,
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monocyte chemoattractant protein-1. At concentrations from 0.62 to 10 µg/ml, the exosomes from
3D-SFnws-cultured HDFs proved their angiogenic power by inducing HDMVECs to form significant
amounts of tubes in vitro.
Conclusions:The structural andmechanical properties of carded/hydroentangled 3D-SFnws proved
their suitability for tissue engineering and regeneration applications. Consistent with our hypoth-
esis, 3D-SFnws-adhering HDFs released exosomes carrying several AGFs that induced HDMVECs
to promptly assemble vascular tubes in vitro. Hence, we posit that once implanted in vivo, the 3D-
SFnws/HDFs interactions could promote the vascularization and repair of extended skin wounds
due to burns or other noxious agents in human and veterinary clinical settings.
Highlights
• This work reports, for the first time, the structural and mechanical features of novel carded and hydroentangled
3D-SFnws fitting the requirements for human soft tissue engineering/regeneration.
• Adult HDFs adhering to such carded/hydroentangled 3D-SFnws continued growing, metabolizing D-glucose and
extracellularly releasing exosomes for at least 15 days in vitro.
• The exosomes released from 3D-SFnws-adhering HDFs carried high amounts of 10 different angiogenic/growth
factors that powerfully induced human dermal microvascular endothelial cells to rapidly form tubes in vitro.
• These findings suggest that by interacting with local HDFs, grafted 3D-SFnws would crucially advance the
vascularization and healing of extended and deep skin wounds caused by burns or other noxious agents.
Key words: Silk fibroin, Nonwovens, Dermis, Fibroblast, Human endothelial cell, Exosome, Cytokine, Chemokine,
Angiogenesis, Regeneration, Tissue engineering
Background
Silk fibroin (SF) is a fibrous biomacromolecule of natural
origin [1]. Native Bombyx mori SF microfibers are used not
only to weave cloths but also to produce biomaterial scaffolds
[2]. The best balance between biocompatibility, mechanical
properties and biodegradability makes SF an excellent sub-
strate for scaffolds suitable for guided tissue engineering and
regenerative medicine applications [3]. Moreover, SF allows
for a highly versatile scaffold design, thanks to the many
processing options that one can implement [4]. Besides native
SFmicrofibers, several regenerated SFmaterials, such as films,
hydrogels, porous sheets, electrospun mats and nanofibers,
have attracted intense interest as implantable medical devices.
The host reaction in terms of tissue–implant interface dynam-
ics, de novo vascularization and immune response is crucial
for the successful clinical outcome of grafted devices [5]. In
recent years, several kinds of SF scaffolds have been preclini-
cally tested in vitro and in vivo using small and large animal
models; some of these devices have reached the clinical trial
stages, and a few have entered the market [6].
In the context of skin tissue engineering and regeneration
we are interested in SF-based scaffolds structured as nonwo-
vens [7–10]. In earlier studies, we investigated the in vitro
and in vivo biological responses evoked by two novel types
of 3D SF-based nonwovens (3D-SFnws) made of randomly
oriented native SF microfibers either glued with formic acid
(FA) or interlaced by combining carding and needling textile
technologies [8–10]. Observations lasting for up to 6 months
revealed for the first time the results of implanting either
of these 3D-SFnws into the subcutaneous layer of C57/BL6
mice.Histological studies showed that the biocompatibility of
3D-SFnws was quite good as they only elicited a mild foreign
body response with no sign of fibrosis or encapsulation. This
is most interesting, since the first week after grafting abundant
proliferating capillaries with an accompaniment of fibrob-
lasts migrated first along the microfibres of both types of 3D-
SFnws prior to colonizing the interposed voids. The upshot
was the guided generation of a well-vascularized reticular
connective tissue, which incorporated the SF microfibers and
filled the intercalated spaces [8, 10]. However, the biological
mechanism underlying the effective vascularization of the
in vivo newly formed reticular connective tissues remained
unknown.
Notoriously, human dermal fibroblasts (HDFs) release
compounds such as growth factors, enzymes, cytokines and
chemokines. These are cell-to-cell signalling polypeptides or
small soluble proteins that play relevant roles in angiogenesis,
cell growth, cell differentiation, inflammation, innate immu-
nity and apoptosis [11–16]. Cellular mechanisms other than
the classical exocytosis partake in such signalling, including
the discharge of variously sized membranous extracellular
vesicles. The latter include nanoscale (diameter, 30–120 nm)
vesicles, which are named exosomes, carrying specific provi-
sions of proteins, lipids, DNA and RNAs [17–19]. Exosomes
are advantageous because they allow the concentration and
delivery of cytokines, chemokines, angiogenic growth factors
(AGFs) and other agents to adjacent or distant cells via the
extracellular matrix (ECM), blood, saliva, urine and cere-
brospinal fluid. This can happen because exosomes protect
their cargoes from breakdown by environmental degradation
mechanisms. The exosomes elicit specific biological responses
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surface of cells, from which the cellular receptors for most
cytokines, chemokines and AGFs stick out. Thus, exosomal
cargoes can effectively modulate intracellular signalling path-
ways, homeostatic mechanisms, antigen presentation, angio-
genesis, coagulation, inflammation and apoptosis [20–23].
Several laboratories have reported that exosomes released
from various cell types, such as mesenchymal stem cells and
endothelial cells (ECs), promote regeneration of vascular ECs
and angiogenesis [24, 25]. Based upon our in vivo observa-
tions [8, 10], we posited that mouse fibroblasts which had
met the implanted 3D-SFnws may have released exosomes
carrying a powerful mixture of angiogenic factors. To evalu-
ate this hypothesis and its potential relevance in translational
medicine, we devised an experiment using HDFs cultured
on a novel 3D-SFnws scaffold to assess the contents and
amounts of any AGFs carried by the HDF-released exosomes.
We reported here that adult HDFs adhering to the novel
3D-SFnws release exosomes carrying 18 different AGFs in
protein form, of which 10 are in amounts much higher than
in exosomes supplied by HDFs adhering to 2D polystyrene
surfaces. We also showed that the exosomes from 3D-SFnws-
adhering HDFs exert a powerful angiogenic effect on human
dermal microvascular endothelial cells (HDMVECs) in vitro.
These findings support the view that such novel 3D-SFnws
scaffolds, once implanted in burn or trauma wound beds,
would promote their own vascularization and cellular colo-
nization, thus successfully advancing tissue engineering and
regeneration and healing.
Methods
Production of the carded/hydroentangled 3D-SFnws
Sericin-deprived (via standard de-gumming) spun silk from
comber waste in staple form (average fibre length, 50±7mm)
was the starting material used to produce the 3D-SFnws.
This SF material underwent processing in a cotton-type flat
carding machine (width, 100 cm). Web formation by carding
arranged the fibres in bundles that took a preferential length-
wise orientation, i.e. an alignment in the longitudinal direc-
tion of the nonwoven web (henceforth indicated as machine
direction (MD)). Next, the carded web received on both its
surfaces a mechanical hydroentanglement that created several
bonding points on it [26].
Scanning electron microscopy (SEM)
To be morphologically analysed, 3D-SFnws were sputter
coated with Au/Pd under a reduced-argon atmosphere in
a Desk IV Coating System (Denton Vacuum, USA) and
observed in a Zeiss EVOMA10 scanning electron microscope
under the following conditions: 10 kV acceleration voltage,
100 mA beam current and 15 mm working distance.
Attenuated total reflectance Fourier transform
infrared spectroscopy
An ALPHA Fourier transform infrared spectrometer (Bruker,
Italy) equipped with an attenuated total reflectance platinum
diamond accessory served to analyse the samples by collecting
65 scans at a 4 cm−1 resolution in the infrared 4000–400 cm−1
wavenumber range. Spectra were corrected with a linear
baseline and normalized to the CH2 bending peak at about
1445 cm−1, a peak notoriously insensitive to the molecular
conformation of SF.
Differential scanning calorimetry
A calorimeter (DSC 3500 Sirius, Netzsch, Germany) deter-
mined the thermal properties of the SF nonwovens. Samples
(3–5 mg) were sealed in aluminium pans and subjected to
a heating cycle from 50◦C to 400◦C, at a heating rate
of 10◦C/min, under a sweeping N2 atmosphere (flow rate,
20 ml/min).
Physical properties and tensile measurements
Thickness, mass per unit area and density per unit volume
of 3D-SFnws were measured according to the UNI EN ISO
5084:1998 and UNI EN 12127:1999 standard methods. The
values of stress, strain and Young’s modulus of 3D-SFnws
in both the MD and the transversal direction (TD) were
calculated from the load elongation curves recorded under
wet conditions. Before analysis, an overnight soaking in water
of test specimens 100 mm long and 10 mm wide achieved
full hydration. After removing the excess water with blotting
paper, specimens were clamped on the jaws of the tensile
testing machine (Instron 3345, Instron, Italy) equipped with a
500 N load cell. The gauge length was 50 mm.Measurements
were conducted at a temperature of 20◦C with a relative
humidity of 65%. After applying a preload of 0.5 N the
test was run at 50 mm/min crossbar rate. Six specimens of
3D-SFnws were analysed for either direction. The thickness
of 3D-SFnws, measured according to ISO 5084:1996, was
0.55±0.03 mm.This value served to calculate the stress from
experimental load values.
Preparation of 3D-SFnws for in vitro cell cultures
After a thorough washing in phoshate buffer saline (PBS), 3D-
SFnws samples were transversally cut into rectangular pieces
measuring 66×23 mm, sealed in pouches and sterilized at
55◦C for 3 hours via exposure to an ethylene oxide/CO2
(10/90 v/v) mixture under a pressure of 42 psi in a vac-
uum oven. Next, specimens were kept for 24 hours in an
aeration room followed by an 8-hour degassing at 50◦C
in a vacuum oven. Prior to use, the sterilized 3D-SFnws
were systematically tested by checking for the absence of
morphological changes and the maintenance of mechanical
properties. Finally, the sterilized 3D-SFnws samples were
aseptically transferred to 4-well, multi-dish lidded, sterile,
polystyrene culture plates (Cat. No. 176597, Nalge Nunc
International, USA). Sterilized steel rods flattened the edges
of the 3D-SFnws samples at the bottom of the plates.
Cells
HDFs were bought from ScienCell Research Laborato-
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Applications (USA), that the HDFs expressed fibronectin
and were negative for immune deficiency virus, hepatitis B
virus, hepatitis C virus, mycoplasma, bacteria, yeasts and
fungi. The standard culture medium for the HDFs was
Dulbecco’s minimum essential medium (DMEM) (89% v/v;
Life Technologies Italia, Italy) supplemented with heat-
inactivated (at 56◦C for 30 minutes) foetal bovine serum
(FBS) (10% v/v; Life Technologies Italia) and penicillin–
streptomycin solution (1% v/v; Lonza, Italy).
HDMVECs isolated from adult skin capillaries were
sourced from Cell Applications (USA). The seller pledged
that such cells were free from bacteria, yeasts, fungi and
mycoplasma, and that they expressed the factor VIII-related
antigen. HDMVECs were grown in endothelial cell growth
basal medium (PromoCell, Germany) supplemented with
10% v/v inactivated FBS; for the experiments, the standard
FBS was changed to bovine exosome-depleted FBS.
Preparation of cell culture medium devoid of bovine
exosomes
To ensure that the exosomes under study came solely from the
HDFs, with no contamination from FBS-carried exosomes,
the experimental growth medium was fortified with a 2.5%
v/v exosome-depleted FBS. To achieve this, prior to being
added to the cell culture medium the heat-inactivated (at
56◦C for 30 minutes) FBS underwent 2 centrifugations at
100,000× g for 120 min in an Optima TLX ultracentrifuge
using the minirotor type TLA 100.3 (Beckman, USA) [27].
Intravital HDF staining
Prior to their experimental use, 3rd or 4th passage HDFs
were counted using a handheld automated cell counter
(Scepter, Merck, Germany) according to the manufacturer’s
instructions. To highlight the cells adhering to the 3D-SFnws
just prior to seeding, 2× 106 HDFs were intravitally stained
with fluorescent lipophilic membrane dyes (tracers): the red-
orange fluorescent 1,1′-Dioctadecyl-3,3,3′,3′-tetramethyl-
indocarbocyanine perchlorate (fluorescence excitation λmax,
549 nm; emission λmax, 565 nm) or the green fluorescent
3,3′-Dioctadecyl oxacarbocyanine perchlorate (fluorescence
excitation λmax, 484 nm; emission λmax, 590 nm) (both from
Thermo Fisher Scientific, Italy). These dyes were dissolved
in dimethyl-sulfoxide, DMSO and used to intravitally stain
HDFs according to the manufacturer’s instructions. For each
experiment, 4 equal aliquots (5×105 each) of pre-stained
HDFs were carefully seeded onto four 3D-SFnws scaffolds
placed inside separate Petri dishes (diameter, 10 cm; Thermo
Fisher Scientific, Italy). For comparative purposes, equal
aliquots (5×105 cells each) of pre-stained HDFs were seeded
in parallel onto 4 identical polystyrene Petri dishes. The cell
cultures of both groups were incubated for 15 days at 37◦C in
a 95% v/v air, 5% v/v CO2 atmosphere. HDFs were regularly
seen under an inverted fluorescence microscope (IM35, Zeiss,
Germany) fitted with proper excitation and emission filters.
All the later procedural steps were the same for the control
group and the experimental group.
PicoGreen DNA quantification
To estimate the cell proliferation onto 3D-SFnws, DNA cellu-
lar contents were assessed by the Quant-iT PicoGreen dsDNA
Kit (Thermo Fisher Scientific). Three specimens of HDFs
cultured on 3D-SFnws were assessed at experimental days 3
and 15.After washing the cells in PBS, 8ml of deionized water
was added to the wells to detach and lyse the cells. Repeated
vortexing and two freezing–thawing cycles improved cell
lysis. DNA amounts were then fluorometrically measured at
excitation λ 480 nm and emission λ 520 nm. A standard
double strand DNA curve of known concentrations was used
to calibrate the fluorescence intensities.
Assay of D-glucose consumption
Cell D-glucose cumulative consumption was assessed in con-
ditioned growth media samples from HDFs cultured on 3D-
SFnws by a glucose oxidase assay using the Amplex Red
Glucose/Glucose Oxidase Assay Kit (Thermo Fisher Scien-
tific, Italy). Glucose oxidase reacted with D-glucose to form
D-gluconolactone and hydrogen peroxide via horseradish
peroxidase. Hydrogen peroxide reacted with the Amplex Red
reagent in a 1:1 stoichiometric ratio to generate the red-
fluorescent product resorufin, the intensity of which was
recorded fluorometrically at excitation and emission wave-
lengths of 560 and 590 nm, respectively.
Isolation and quantification of exosomes
HDF-conditioned media of both experimental and control
groups were collected at 72-hour intervals and centrifuged at
2000× g for 30 minutes at 4◦C to remove cells and debris.
The resulting supernatants were stored at −80◦C for later
analysis. After thawing, the supernatants of either group were
pooled and the corresponding total exosomal fractions were
extracted using the Total Exosome Isolation Reagent for
cell culture media (No. 4478359, Thermo Fisher-Invitrogen,
USA) following the manufacturer’s protocol with slight mod-
ifications. Briefly, the supernatants were centrifuged for 30
minutes at 15,000× g, mixed with the proprietary reagent,
incubated overnight at 4◦C and then centrifuged again for
90 minutes at 10,000× g at 4◦C. The exosome fractions
were contained in the final pellets. This procedure has been
compared with others and validated [28]. The total proteins
of the exosome fractions were quantified using Bradford’s
method. The marker-based assessments of exosomal prepara-
tions were completed using an enzyme-linked immunosorbent
assay (ELISA) kit that detects the CD9 marker (ExoTEST™,
HansaBio Med, Estonia). Notably, CD9 is a tetraspanin pro-
tein intensely expressed by fibroblasts and a typical marker
present at the membrane surface of HDF-released exosomes
[29]. Therefore, equal amounts of exosomal proteins from
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Identification and quantitation of exosome-carried
AGFs
The several exosome-carried AGFs were identified and quan-
tified with the Human Angiogenesis Antibody Array C1000
(RayBiotech,USA) according to the manufacturer’s protocols.
Briefly, equal amounts of exosomal proteins of the control
and experimental group were diluted in 2.0 ml PBS and then
incubated with the antibody arrays, which had been pre-
treated for 30 minutes with Odissey blocking buffer (LI-
COR, USA). After an overnight incubation at 4◦C and a
thorough washing, the array membranes were incubated for 2
hours with 1.0 ml of a mix of array-specific biotin-conjugated
primary antibodies, diluted 1:250 in Odissey blocking buffer.
Finally, the membranes were incubated at room temperature
for 1 hourwith 2.0ml of DyLight800-conjugated streptavidin
(KPL, USA), diluted 1:7500 in Odissey blocking buffer. The
positive signals of the several AGFs were acquired with
an Odissey scanner (LI-COR, USA) and their densitomet-
ric values quantified by using the Image Studio software
package (version 5.2, LI-COR, USA). Each array’s positive
signal intensity values were normalized via comparisons to
correlated positive controls. The results from 3 independent
experiments were averaged and expressed as mean values ±
standard deviations (SDs). This technology provides several
advantages: (1) it allows the performance of high-content
screening using about the same sample volume as required by
traditional ELISAs; (2) it improves the chances of discovering
key factors while maintaining an ELISA-like sensitivity; (3)
it has a wider detection range, i.e. 10,000-fold, than typical
ELISAs (i.e. 100–1000-fold); and (4) it has a lower inter-array
coefficient of variation of spot signal intensities (∼5–10%)
than typical ELISAs (∼10–15%).
Endothelial tube formation assay
The pro-angiogenic properties of exosomes released from
HDFs grown on 3D-SFnws scaffolds were assessed using
HDMVECs and the PromoKine Angiogenesis Assay Kit (Cat.
No. PK-CA577-K905, PromoCell,Germany) according to the
manufacturer’s instructions. Briefly, HDMVECs were grown
at 37◦C in air with CO2 5% v/v until reaching about 90%
confluency in endothelial cell growth basal medium (Cat. No
C-22210, PromoCell, Germany) with added supplement mix
(Cat. No C-39215, PromoCell, Germany). Next, HDMVECs
were harvested using trypsin 0.025% v/v and resuspended
in endothelial cell growth basal medium fortified with 2.5%
v/v exosome-depleted FBS. Then, an aliquot (50 µL) of ECM
solution was added to each well of a 96-well sterile cell
culture plate kept on ice that was thereafter incubated at
37◦C to form a gel. After that, 20× 103 HDMVECs sus-
pended in 100 µL culture medium were mixed with different
concentrations (i.e. 0.625, 1.25, 2.5, 5.0 and 10.0 µg/ml)
of exosomes from 3D-SFnws-adhering HDFs or with no
exosomes (controls on polystyrene ± ECM gel) and directly
added to each well. Finally, the plates were incubated at 37◦C
in air with CO2 5% v/v for 5 hours.HDMVECswere checked
and photographed at ×400 magnification under an IM35
microscope with an Olympus DP10 digital camera (Olympus,
Japan). The mean tube lengths in µm per microscopic field
at ×100 magnification were quantified via morphometric
methods [30]. Triplicate results were averaged and expressed
as the means ± SDs.
Statistical analysis
Data were expressed as mean values ± SDs. Descriptive
statistical analyses were conducted using the Analyse-it
software package (Analyse-it, UK). A Shapiro–Wilk test
showed that the data groups had normal distributions. A one-
sided Student’s t-test served to assess the level of statistical
significance between differences of data means from HDFs
cultured on 3D-SFnws versus HDFs cultured on polystyrene.
A one-way analysis of variance with a post hoc Tukey’s
test served for multiple comparisons of the results from
endothelial tube formation assays. The statistical significance
level was set at p < 0.05.
Results
Morphological, physical, chemical, and mechanical
features of the novel 3D-SFnws
Fibres of a 50±7 mm length made the carded/hydroentan-
gled 3D-SFnws, which were 520 µm thick, weighed 58 g/m2
and had a density of 105 g/m3.
Scanning electron microscopy observations revealed the
surface morphology and fine structure of these 3D-SFnws
(Figure 1a, b, c). The SF microfibres formed a network limit-
ing a high number of intercommunicating voids. At first sight,
the pictures are similar to those other two previously pub-
lished proper types of SF-based nonwovens [8, 10]. However,
at low magnification (Figure 1a) it becomes manifest that the
preferential orientation of the SF microfibers corresponds to
the direction (or MD) of the web carding. Figure 1b shows
the details of a bonding point, where the SF fibres were
forced to become twisted together by the mechanical action
of the water (hydroentangling). The 3D-SFnws microfibres
have a diameter ranging from 7 to 14 µm and no film-like or
other structure linking them together. In fact, the void spaces
interspersed between the microfibers are clear. In addition,
Figure 1c documents the clean and smooth surface of the
3D-SFnws microfibres, proving the perfect sericin removal.
The chemical and physical characterization of the
3D-SFnws was performed via infrared spectroscopy (attenu-
ated total reflectance Fourier transform infrared), differential
scanning calorimetry and stress/strain application.
Figure 1d showed the typical attenuated total reflectance
Fourier transform infrared spectrum of the 3D-SFnws
samples from the 2000 to 800 cm−1 wavenumber range.
Such a spectral range is the fingerprint of SF, as it shows
several absorption bands strongly affected by its physical
and chemical structure [31, 32]. The bands at 1618 cm−1
(amide I), 1510 cm−1 (amide II) and 1227 cm−1 (amide
III) are typically SF conformation sensitive as they arise
from different vibrational modes of the peptide bond. The
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Figure 1. Silk fibroin (SF) microfibers and their nodes in the novel 3D SF nonwovens (3D-SFnws) produced via the carding/hydroentanglement technology.
Scanning electron microscopy at low (×50) (a), medium (×500) (b) and high (×5000) (c)magnifications. In (a), the white arrows show the machine direction (MD)
and transversal (TD) direction, respectively, of the 3D-SFnws fabrics. (d) Attenuated total reflectance Fourier transform infrared spectroscopy (FTIR) spectrum
of the 3D-SFnws in the 2000 cm−1 to 800 cm−1 wavenumber range. The bands of Amide I at 1618 cm−1, Amide II at 1510 cm−1 and Amide III at 1227 cm−1,
with a shoulder at about 1261 cm−1, are typical of the β-sheet molecular conformation of crystalline and oriented SF fibres. (e) Differential scanning calorimetry
(DSC) thermogram of the novel 3D-SFnws. The strong melting/degradation peak at 319◦C characterizes the SF fibres with a high degree of molecular order
and crystallinity. (f) Representative stress/strain curves of the novel 3D-SFnws in the MD and the TD under wet conditions. Electron high tension, EHT; working
distance, WD; magnification, Mag.
the repetitive Gly-Ala and Gly-Gly sequences of the SF
chain, respectively. Altogether, these bands give back the
image of a native silk material with a highly stable β-sheet
molecular conformation typical of the crystalline and
oriented SF fibres.
Figure 1e shows the differential scanning calorimetry ther-
mogram of the 3D-SFnws. It demonstrates a strong melt-
ing/degradation peak at 319◦C that again is characteristic of
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Table 1. Tensile properties of 3D silk fibroin nonwovens
Carded-hydroentangled Carded-needled [10] FA-crosslinked [8, 9]
MD TD MD/TD MD/TD
Stress (MPa) 6.91± 0.3 1.8 ± 0.1 2.5± 0.6 4.9± 0.6
Strain (%) 26± 2.0 0.80 ±0.1 49.4± 5.9 21.4± 2.5
Young’s modulus
(MPa)
38.4± 1.6 1.9 ± 0.3 8.0± 1.6 34.4± 2.7
Carded-hydroentangled nonwovens are stronger (value of stress is significantly higher than the other 2), less elastic than carded-needled nonwovens (value
of strain is about one-half) but more elastic than FA-crosslinked nonwovens. The Young’s modulus estimates the degree of stiffness, which is the resistance
to deform following the application of a small load. Carded-hydroentangled nonwovens are as stiff as FA-crosslinked nonwovens in the MD but much more
pliable and compliant than the other 2 nonwovens in the TD. The carded-needled and FA-crosslinked nonwovens have identical mechanical properties in the
2 directions. Data are mean value ± standard deviation. FA formic acid,MD machine direction, TD transversal direction
Moreover, Figure 1f shows representative stress/strain
curves of the 3D-SFnws in the MD and the TD [32]. The
corresponding tensile measurements reported in Table 1
confirm the mechanical robustness of the 3D-SFnws. As
expected, a clear mechanical anisotropy along the two axes
characterizes these scaffolds. The latter are stronger and
stiffer in the MD due to the preferential alignment of the
lengthy SF fibre bundles caused by the carding process. The
values of stress, strain and Young’s modulus in the MD
are equal or even better than those of the nonwoven silk
matrices we previously reported [8, 10]. On the other hand,
the present 3D-SFnws are much more pliable in the TD
than the earlier nonwoven silk matrices [8, 10] (Table 1).
Altogether, these properties reveal that the current material
is highly performing in terms of meeting the biomechanical
requirements typical of human soft tissue [33]. Translating
into biological terms, according to Wang et al. [34] and
Thurber et al. [3], these properties mean that once implanted
in vivo the 3D-SFnws under study may have a medium- to
long-term degradation profile, hence providing an effective
biomechanical support to the de novo engineering of the
intended biological structure.
Growth and metabolism of HDFs grown on 3D-SFnws
After careful seeding, 70–80% of the intravitally stained
HDFs attachedwithin 3 hours onto the 3D-SFnws.Microscopy
observations confirmed the HDFs numerical increase with
time (Figure 2a, b, c, d). The growth of the adhering cells
between experimental days 3 and 15 was mirrored by
a 4.5-fold increase in the double strand DNA amount
associated to the 3D-SFnws (Figure 2e). Biochemical assays
showed that the cumulative D-Glucose consumption by the
HDFs adhering to 3D-SFnws increased 5.4-fold between
experimental days 3 and 15 in culture, i.e. values paralleling
the HDF numerical increases (Figure 2f). On the other hand,
polystyrene-adhering HDFs started growing after the first 24
hours and kept doing so until they reached confluence by the
14th day (not shown).
AGF amounts released via exosomes from HDFs
grown on 3D-SFnws versus polystyrene
Specific membrane-based double-antibody arrays allowed us
to identify and quantify the AGFs carried by equal amounts
of the pooled exosomes released from HDFs grown on 3D-
SFnws and on polystyrene [35].
Typical developed array membranes—a couple of mem-
branes for each experimental group to cover the whole
series of compounds evaluated—are comparatively shown
in Figure 3a, b, c, d. The results of the arrays showed that
18 out of the 43 potentially discoverable AGFs were carried
by the HDF-released exosomes of both experimental groups
(Figure 3a, b, c, d) (Table S1). The quantitative analysis and
statistical comparison of corresponding spots showed that
the amounts of 10 out of the 18 exosome-carried AGFs from
the 3D-SFnws-grown group were significantly higher and
2 others significantly lower than in the exosomes from the
polystyrene-grown group (p < 0.05) (Figure 4). The highest
percent increases in the 3D-SFnws versus the polystyrene
group were those of tissue inhibitor of metalloproteinase-
1 (TIMP)-1 (+187%), interleukin (IL)-8 (+117%) and
growth-regulated oncogene (GRO)-α, GRO-β and GRO-γ
chemokines (+63%). Lesser but still significant increases in
the 3D-SFnws group versus the polystyrene group were those
of urokinase-type plasminogen activator surface receptor
(uPAR) (+53%), angiopoietin (ANGPT)-1 (+49%), IL-1α
(+48%), ANGPT-2 (+46%) and IL-4 (+40%). Still smaller
percent increases were those of matrix metalloproteinase
(MMP)-1 (+33.5%) and ANGPT-1-R receptor (or Tie-
2; +25%). The remaining 2 factors, tissue inhibitor of
metalloproteinase-2 (TIMP-2) (−25%) and monocyte
chemoattractant protein-1 (MCP-1) (−44%), were signifi-
cantly less abundant in the exosomes from the 3D-SFnws
group than in those from the polystyrene group (Figure 4).
Conversely, the exosomal amounts of the remaining
6 compounds identified—plasminogen/angiostatin, IL-1β,
MMP-9, fibroblast growth factor (FGF)-2, IL-6 and vascular
endothelial growth factor (VEGF)-D—did not significantly
(p>0.05) differ between the 3D-SFnws group and the
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Figure 2. The morphology, growth and metabolic activity of human dermal fibroblasts (HDFs) that had adhered to and colonized the 3D silk fibroin nonwovens
(3D-SFnws). (a, b) Intravitally 1,1’-Dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate pre-stained HDFs on 3D-SFnws seen under a fluorescence
inverted microscope emit a red fluorescence at λ 565 nm due to the lipophilic stain incorporated by their cellular membranes. The 3D-SFnws microfibers do
not emit any interfering fluorescence at λ 565 nm and hence are hardly detectable. Obviously, most of the visible cells are out of focus since they are attached
to a 3D scaffold. However, the cell numbers are noticeably higher at 5 days (b) than at 2 days after plating (a). (c, d) These are the same pictures as in (a) and
(b), respectively, as they appear after digitally removing the red colour. Under these conditions it is possible to detect very thin black stripes at certain sites
running in parallel, which correspond to the SF microfibers of the 3D-SFnws. Some of these stripes run over and cut the images of the underlying cells. Original
magnification in (a) and (b), ×40. (e) HDFs attached to 3D-SFnws significantly increase their numbers during 15 days of staying in vitro as shown by the 4.5-fold
increase in number of the cells adhering to the scaffolds between day 3 and day 15. Double strand (ds) DNA amounts were assayed as detailed in the Methods.
Bars aremean value ± standard deviation (SD) from 3 distinct duplicate determinations at each time point. ∗p< 0.001. (f) The cumulative D-Glucose consumption
of HDFs cultured on 3D-SFnws. D-Glucose levels of the HDF-conditioned media at each time point were gauged as detailed in the Methods. Each dot represents
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Figure 3.Developed double-antibody arraymembranes (each arraymade of 2 different membranes) showing the angiogenic/growth factors (AGFs) carried by the
exosomes released from human dermal fibroblasts (HDFs) grown either as conventional monolayers on polystyrene (a, b) or on 3D silk fibroin nonwovens (3D-
SFnws) (c, d). Equal amounts of exosomes isolated from HDF-conditioned media samples of the 2 experimental groups were used. For technical details consult
the Methods section. The red rectangles include the duplicate dots of each of the AGFs whose exosomal amounts were significantly (p< 0.05) higher, and the
blue rectangles enclose those whose amounts were lower (p< 0.05) when comparing the 3D-SFnws group with the polystyrene group. ANGPT angiopoietin,
GRO growth-regulated oncogene, IL interleukin,MCP-1monocyte chemoattractant protein-1,MMP-1matrix metalloprotease-1, Pos positive control spots, TIMP
tissue inhibitor of metalloproteinases, uPAR urokinase-like plasminogen activator surface receptor
Table 2. Other angiogenic/growth factors carried by equal amounts of exosomes from either group
AGFs Polystyrene group 3D-SFnws group 1% P value
Plasminogen (Angiostatin) 7. 7± 0.72 9.41 ± 0.925 +22.2 0.218
Interleukin-1β 6.94± 0.648 8.37 ± 0.81 +20.6 0.240
Matrix metalloprotease-9 8.24± 0.803 9.53 ± 0.915 +15.7 0.349
Fibroblast growth factor-2/b 37.8± 2.7 43 ± 3.03 +13.8 0.269
Interleukin-6 56.4± 5.39 57.3 ± 5.06 +1.8 0.909
Vascular endothelial growth factor-D 27.0± 2.87 24.9 ± 2.38 -7.8 0.603
Data are mean value± standard deviation of the densitometric integral intensity assessments for each factor from 3 independent experiments each with duplicate
determinations. Numbers shown are the original values ×103
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Figure 4.Significantly changed exosomally carried AGFs are here tiered as (1) those affecting pro-angiogenic (MMP-1, TIMP-1, uPAR) and anti-angiogenic (TIMP-2)
ECM remodelling (a–d); (2) thosemainly angiogenic (ANGPT-1, ANGPT-2, Tie-2) and proinflammatory (MCP-1) (e–h); and (3) those both angiogenic andmitogenic
(IL-1α, IL-4, IL-8, GRO-α, GRO-β and GRO-γ ) (i–l). In detail, (a) MMP-1; (b) TIMP-1; (c) TIMP-2; (d) uPAR; (e) ANGPT-1; (f) ANGPT-2; (g) Tie-2; (h) MCP-1; (i) IL-1α; (j)
IL-4; (k) IL-8; (l) GRO-α, GRO-β and GRO-γ . These factors were assayed as detailed in the caption for Figure 3 on equal amounts of exosomal proteins from either
experimental group. The bars are mean value ± standard deviation from 3 distinct experiments, each conducted in duplicate. The corresponding p values of the
differences between each couple of bars are also shown. ANGPT angiopoietin, ECM extracellular matrix,GRO growth-regulated oncogene, IL interleukin,MCP-1
monocyte chemoattractant protein-1,MMP-1matrix metalloprotease-1, TIMP tissue inhibitor of metalloproteinases, uPAR urokinase-like plasminogen activator
surface receptor
Induction of human endothelial tube formation
by exosomes released from 3D-SFnws-adhering HDFs
Finally, we assessed whether the AGFs carried by the
exosomes released from 3D-SFnws-adhering HDFs might
induce HDMVECs to assemble tubes in vitro. Control
HDMVECs plated on plastic or ECM gel in 2.5% v/v
exosome-depleted FBS medium exhibited only a minimal
ability to form tubes (Figure 5a, b). Conversely HDMVECs
plated onto ECM gel formed extensive tubular networks
in response to the exposure to exosomes released from 3D-
SFnws-adheringHDFs (Figure 5c). The conspicuous increases
in lengths of the endothelial tubes per microscopic field
were alike (p>0.05) for all the tested amounts of added
exosomes (Figure 5d). Therefore, the AGFs carried by the
exosomes released from 3D-SFnws-adhering HDFs exerted
an intense angiogenic activity when contacting HDMVECs
in vitro.
Discussion
The present carded/hydroentangled 3D-SFnws are scaffolds
entirelymade of native SFmicrofibres in β-sheet form isolated
from the domesticated silkworm B. mori. They represent a
technological evolution when compared with the previously
reported FA-crosslinked [8] and 3D carded-needled nonwo-
vens [10]. Indeed, both the earlier prototypes performed quite
well in terms of biocompatibility and host response following
a long-term (up to 6 months) subcutaneous implantation.
However, the FA-crosslinked nonwoven was unsatisfactory
in terms of biomechanical characteristics. The fact that it
remained rather stiff even after an extensive hydration raised
serious concerns about its translatability into clinical set-
tings. The second prototype was manufactured according to
the carding-needling nonwoven technology, which allowed
avoidance of the use of FA as the chemical stabilizer of
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Figure 5. Exosomes released from 3D silk fibroin nonwovens (3D-SFnws)-adhering human dermal fibroblasts (HDFs) induce human dermal microvascular
endothelial cells (HDMVECs) to form tubes in vitro. (a) Micrograph showing plain polystyrene-adhering HDMVECs 5 hours after seeding into a 96-well plate. In
each of these wells 20× 103 HDMVECs were incubated at 37◦C in endothelial cell growth basal medium fortified with 2.5% v/v exosome-depleted foetal bovine
serum. No HDF-released exosomes were added. (b)Micrograph showing HDMVECs 5 hours after seeding onto extracellular matrix (ECM) gel. Save for the latter,
the conditions used were the same as in (a). (c) Micrograph showing HDMVECs 5 hours after seeding onto ECM gel while being simultaneously exposed to
0.625 µg/ml of exosomes released from 3D-SFnws-adhering HDFs: all the other conditions as in (a) and (b). Endothelial tube formation was strongly induced by
the HDFs exosomes. (a–c) Phase contrast microscopy; original magnification, ×100. (d) Bar graph showing the total length (in µm) of newly formed endothelial
tubes per microscopic field under the conditions of the test, i.e. (1) control HDMVECs cultured on plain polystyrene (CTR-P) with no addition of exosomes
released from 3D-SFnws-adhering HDFs; (2) control HDMVECs cultured on ECM gel (CTR-M) with no addition of exosomes set free from 3D-SFnws-adhering
HDFs; and (3) HDMVECs cultured on ECM gel exposed to increasing concentrations of exosomes released from 3D-SFnws-adhering HDFs. Tube formation assay
was performed as detailed in theMethods section. The total tube length (in µm)/microscopic field of 332,667 µm2 area was found via morphometric methods [30]
on pictures taken at ×100magnification of 5microscopic fields for each exosomal concentration. Triplicate results were averaged and the bars show themeans ±
standard deviations. As compared to CTR-P or CTR-M, in the total absence of exosomes, the HDMVECs treated with exosomes released from 3D-SFnws-adhering
HDFs showed by 5 hours huge increases in the length of endothelial tubes that were dose-independent in the range evaluated. Pairwise one-tailed Student’s
t-test and one-way analysis of variance with post hoc Tukey’s test were used for statistical analysis. ∗p< 0.05 vs CTR-P; #p< 0.05 vs CTR-M. Conversely, no
statistical difference (p> 0.05) in tube length at 5 hours occurred on one hand between CTR-P and CTR-M and on the other hand within the several doses of
exosomes evaluated (not shown)
behaviour, the present carded-needled scaffold features were
more closely compliant with those of soft biological tissues
[10]. However, if on the one hand the use of short length
(<25 mm) SF microfibers eased the processing of the raw
material with the nonwoven technology, it also led to the pro-
duction of a very thin (130 µm) sheet that was difficult to han-
dle without its structure becoming misshaping. Regarding the
present 3D-SFnws scaffolds, the use of longer SF microfibers
(50mmor a little more) and the shift from nonwoven carding-
needling to flat carder-hydroentanglement technology [26]
allowed us to produce thicker and mechanically more robust
scaffolds. In fact, the 3D-SFnws nonwovens keep all the most
appreciable characteristics of the carded-needled prototype
(i.e. softness, lightness and interconnected porosity), display
an outstanding handling stability (can be safely cut to realize
any required size and shape) and provide the opportunity
for modulating the biomechanical responses over a wider
range of stress and strain values. Moreover, thanks to their
mechanical anisotropy, the 3D-SFnws scaffolds are better
suited to fulfil the mechanical requirements of soft tissues,
such as skin, when subjected to directionally oriented lines of
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promising material for the engineered repair and regeneration
of soft tissues.
Obtaining an efficient vascularization is one of the cru-
cial problems met when people take aim at engineering/
regenerating a body tissue under the guidance of a bioma-
terial scaffold. An inadequate fulfilment of this target entails
serious failures of various degrees. Earlier works from our
laboratories showed that the earlier two types of 3D-SFnws
implanted into the subcutaneous tissue of C57/BL6 mice
were rapidly invaded by newly formed vessels growing first
along the SF microfibres and later into the intercalated voids.
This intense neoangiogenesis allowed the guided engineer-
ing/regeneration of a reticular connective tissue to occur.
Between 3 and 6 months later, the newly formed, and by then
mature, reticular connective tissue differed from its normal
counterpart only by the presence of the SF microfibres and
sporadic polynucleated giant cells with no sign at all of fibro-
sis, encapsulation or thickening of the overlying epidermis
[8, 10].
The present results prove, as we hypothesized, that a mech-
anism based on the release of exosomes carrying significant
surpluses of 10 AGFs on the part of 3D-SFnws-adhering
HDFs could drive their early vascularization and colonization
once grafted to a human tissue in vivo. In fact, a tube
formation assay showed that the same exosomes powerfully
stimulated HDMVECs to produce significant amounts of
new tubes, thereby proving their biological pro-angiogenic
potential. Previously, Shabbir et al. [24] reported that an
exposure to exosomes released from mesenchymal stem cells
significantly activated protein kinase B/Akt and STAT3 via
specific phosphorylations while enhancing the signalling
of extracellular-related kinase (ERK)1/2 in normal HDFs.
However, further studies will clarify the signalling mech-
anisms driven by the attachment of the HDFs to 3D-
SFnws. Once grafted onto wound sites, the 3D-SFnws will
rapidly and effectively promote their own vascularization and
cellular colonization through the exosomal release of
multiple AGF surpluses from the adhering HDFs (Figure 6).
This locally induced neoangiogenesis will increase the SF
nonwoven implants success probability, as seen in earlier
experiments carried out in rodents in vivo [8, 10].
We must mention here studies using different 3D cell
culture models in vitro releasing exosomes that were more
effective in improving angiogenesis and/or functional recov-
ery of various kinds of damaged tissues than those from
conventional monolayer (2D) in vitro models [18, 36–39]. It
is obvious that a 3D environment is more conducive than a
2D one to neoangiogenesis, thereby enhancing skin wound
healing [40]. The other hidden advantage of SF-based 3D
scaffolds in relation to translational medicine is that humans
and other mammals have about 50 if not more proteins
that contain significant stretches of conserved amino acid
sequences that can be already found in B. mori’s SF. This
explains the remarkable biocompatibility of the SF-based
scaffolds [8, 10, 41].
Finally, the potential biological and applicative impact of
each of the AGFs exosomally over-released from 3D-SFnws-
adhering HDFs is highlighted in the following paragraphs.
MMP-1, TIMP-1, TIMP-2 and uPAR
According to available data, exosomes carry on their surface
discrete amounts of several functionally active proteases,
including MMP-1, MMP-2, MMP-3, MMP-9 and MMP-
13, ADAM (disintegrin and metallopeptidase domain)-
10, ADAM (disintegrin and metallopeptidase domain)-17,
hyaluronidase (a glycosidase) and uPAR [42]. The exosomal
surface proteases bind and degrade ECM proteins like
collagens, laminin and fibronectin. Thus, exosomal proteases
modulate the structure of the ECM, thereby creating spaces
for newly formed vessels and vessel-associatedmigrating cells,
promoting neoangiogenesis and wound repair.
The present results show that the exosomes released from
HDFs cultured on 3D-SFnws carried significantly greater
amounts of MMP-1 and its regulatory factor, TIMP-1,
than did exosomes freed from HDFs grown on polystyrene.
Reportedly, MMP-1 induces angiogenesis by degrading the
type I collagen of the ECM and activating the protease-
activated receptor-1 [43]. In addition, by blocking the activity
of MMP-9, MMP-1 decreases the basal levels of the 24 kDa
powerful angiostatic tumstatin, an MMP-9-cleaved fragment
of type IV collagen [44, 45].Of note, the cumulative exosomal
contents of MMP-9 did not significantly differ between the
2 experimental groups studied. It is relevant to mention here
that an increased expression of both TIMP-1 and TIMP-
3 can stabilize the basement membrane and regulate ECM
remodelling and angiogenesis at the level of wound beds,
thereby promoting epidermal regeneration [46]. Moreover,
Lu et al. [47] showed that TIMP-1 overexpression activated
the phosphoinositide 3-kinase/phospho-Akt pathway, but not
the ERK or p38 mitogen-activated protein kinase pathways,
thus stimulating the proliferation of mouse NIH-3 T3
fibroblasts in an MMP-independent manner. Conversely,
other studies reported that TIMP-1’s mitogenic action is
MMP-dependent [48].
Our findings show that exosomes released from HDFs
cultured on 3D-SFnws carried lesser amounts of TIMP-2
than those from polystyrene-adhering HDFs. TIMP-2 is an
endogenous MMP inhibitor which blocks the proliferation
of capillary ECs and hence angiogenesis in vivo [49]. Inter-
estingly, according to the available evidence, TIMP-2 exerts 2
distinct anti-angiogenic activities: anMMP-dependent one on
embryonic neovascularization and anMMP-independent one
that inhibits both normal and mitotic factor-driven angiogen-
esis in vivo [49, 50]. Therefore, this decreased exosomal con-
tent of TIMP-2 would strengthen the pro-angiogenic actions
of other factors carried by the exosomes released from SF-
adhering HDFs.
Our present results also revealed that the exosomes from
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Figure 6. Schematic diagram depicting that human dermal fibroblasts (HDFs) attached to 3D silk fibroin nonwovens (3D-SFnws) (top) release into a wound’s
connective tissue (bottom) exosomes (EX) carrying surpluses of angiogenic growth factors (AGFs). The transported AGFs are freed onto the external surface of
endothelial cells (ECs) of adjoining capillaries and of neighbouring HDFs, thereby activating the proliferation and mobilization of both. The result (not shown
but suggested by thick brown-red and black arrows pointing upwards to the 3D-SFnws) is the formation of novel proliferating vessels that invade and colonize
the 3D-SFnws graft together with the coming along HDFs. The vascularization and colonization of the SF microfibres and interposed voids end up engineering
a new connective tissue differing from the normal one only by the biocompatible SF microfibres [8, 10]
amounts of uPAR, a highly glycosylated, GPI-anchored
receptor endowed with 3 extracellular domains (D1–D3).
Cleavage between D1 and D2 generates the uPAR D2-
D3 fragment, which can be split further [51]. The uPAR
ligand, named urokinase-type plasminogen activator (uPA),
not only lyses fibrin clots but is also involved in biological
processes like angiogenesis, wound healing, embryogenesis,
cell migration, inflammation and apoptotic cell death [52].
The onset of angiogenesis critically requires uPA/uPAR-
induced ECM degradation [53]. Moreover, uPA/uPAR
complexes advance angiogenesis by quelling the expression
of their crucial negative regulator, the phosphatase and
tensin homolog [54]. Importantly, uPA/uPAR complexes also
promote the discharge of various AGFs, like basic FGF/FGF-
2 and VEGF, which promote the proliferation of ECs and
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vitronectin advances adhesion andmigration of ECs [56]. The
suppression of uPA/uPARwith anti-uPA and anti-uPAR short
hairpin RNAs significantly hindered the pro-angiogenesis
signalling by VEGF and granulocyte-macrophage colony-
stimulating factor [57, 58]. Finally, soluble full-length
uPAR- or uPAR-D2-D3-driven signalling cascades accelerated
wound healing via skin epidermal cells, and possibly peri-
wound dermal fibroblasts, in K14-Dsg-2 transgenic mice
overexpressing desmoglein-2, a crucial component of desmo-
somes and a regulator of cell survival/proliferation [59].
ANGPT-1, ANGPT-2, (s)Tie-2, and MCP-1/chemokine
(C-C motif) ligand-2
The present findings show that exosomes released from
HDFs adhering to 3D-SFnws hold significantly higher
amounts of ANGPT-1, ANGPT-2 and ANGPT-1-R (or Tie-2)
than do those from polystyrene-stuck HDFs. ANGPT-1,
ANGPT-2, ANGPT-3 and ANGPT-4 are a group of secreted
glycoproteins that bind with similar affinity of the Tie-
2 receptors of ECs, activating their tyrosine kinases to
phosphorylate their own tyrosine groups. The signalling of
ANGPTs/Tie-2/tyrosine kinase complexes crucially regulates
venous and lymphatic angiogenesis/remodelling and cardio-
vascular development [60, 61]. It also protects the vasculature
against pathological injuries. On the other hand, the hypoxia-
inducible vascular endothelial protein tyrosine phosphatase
dephosphorylates and inactivates the Tie-2 receptor [62].
ANGPTs critically mediate reciprocal interactions between
ECs and the surrounding ECM. ANGPT-1 promotes the
reconstruction and final shape of a mature vascular network
endowed with a stable spatial structure [63–66]. ANGPT-
1 operates through several mechanisms: (1) it activates the
Akt serine kinase, thereby switching on the endothelial nitric
oxide synthase 3 [67] and in turn, nitric oxide synthase 3
protects vessels and promotes EC survival; and (2) it raises
the phosphorylation of the forkhead box O1 transcription
factor, which downregulates the expression of forkhead
box O1 target genes [68, 69]. ANGPT-1 overexpression
at the skin level significantly improved re-epithelialization
and induced a hyper neovascularization. The features of
the latter were an increase in vessel numbers coupled with
an amplification of vessels size, and the recruitment of
endothelial progenitor cells (EPCs) in diabetic wounds. In
addition, exogenously administered ANGPT-1 advanced
an improved neovascularization which depended on EPC
recruitment and exerted beneficial effects on wound re-
epithelialization [63]. Moreover, treatment with ANGPT-
1 increased the serum levels of pro-MMP-9 and stem cell
factor but did not alter VEGF levels [63]. Finally, when co-
administered, ANGPT-1 and VEGF enhanced the formation
of a collateral circulation [70] and controlled blood vessel
growth and permeability [71].
Regarding ANGPT-2, its overexpression increased the
Tie-2 receptor phosphorylation promoting the angiogenesis
via EC tube formation in renal cell carcinoma (RCC) model
mice [72] and the sprouting or regression of vessels in the
ovary [66]. Moreover, at high concentrations ANGPT-2
promotes EC survival via the phosphoinositide 3-kinase/Akt
signal transduction pathway [73].
A final comment deserves the marginally increased
ANGPT-1-R/Tie-2 that occurred in the exosomes released
from 3D-SFnws-adhering HDFs. Whether a regulated
ectodomain cleavage did release, via exosomes, the soluble
ligand-binding domain ((s)Tie-2) of the Tie-2 receptor is
an interesting possibility that is still unproven. But let us
suppose that it were all in the sTie-2 form: what might
it then effect? The work of Alawo et al. [74] answers this
question. They asked whether increased levels of circulating
sTie-2, which occur in cases of myocardial infarction
and/or peripheral arteriopathies, might bind ANGPT-1 and
supress its actions. Their calculations showed that sTie-2
concentrations effectively suppressing ANGPT-1 signalling
must be more than 10-fold higher than those ever detected in
healthy or diseased conditions. Therefore, while a local block
of ANGPT-1 signalling might occur in cells releasing sTie-2,
it is unlikely that the marginal increase in exosomal sTie-2
we observed would hinder ANGPT-1’s angiogenic activity.
In our study, the exosomes from HDFs cultured on 3D-
SFnws carried significantly lesser amounts of MCP-1 than
did those from polystyrene-adhering HDFs. This finding may
at least partly explain why the proinflammatory activities
of 3D-SFnws are weaker than those of polystyrene. MCP-
1, also referred to as chemokine (C-C motif) ligand (CCL)-
2, is a small molecule of the chemotactic cytokine family.
MCP-1/CCL2 attracts dendritic cells,monocytes andmemory
T cells to inflammation sites caused by either tissue injury
or infection. Fibroblasts, ECs, epithelial cells and leucocytes
produce MCP-1/CCL2 during inflammatory processes [75].
A host of CC chemokines, including CCL1, MCP-1/CCL2,
CCL3, CCL4, CCL5 and CCL7, are expressed during the
first post-injury week in human skin wounds, and elevated
levels of MCP-1/CCL2 are detected in human burns [76,
77]. Additionally, the epidermis bordering excisional wounds
expresses MCP-1/CCL2 and CCL3 [78]. In healing wounds,
gradients of CC chemokine released by hyper-proliferating
keratinocytes, fibroblasts and macrophages tightly regulate
local phagocytic cell infiltration [79, 80]. The focal adhesion
kinase (FAK) is a cytoplasmic protein tyrosine kinase that
co-localizes with integrins at sites of attachment to their
ligands. Through extracellular signal-regulated kinase (ERK),
FAK triggers the secretion of MCP-1 following mechanical
stimuli. Fibroblast-specific FAK−/− (knockout) mice exhib-
ited less inflammation and fibrosis than control mice in
a hypertrophic scar formation model. Similarly, MCP-1−/−
(knockout) mice formed minimal scars. These findings show
that inflammatory chemokine pathways are a major mech-
anism by which FAK mechano-transduction induces fibrosis
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IL-1α, IL-4, IL-8/CXCL8, GRO-α GRO-β and GRO-γ
Our present findings show that the exosomes released from
3D-SFnws-adhering HDFs carried higher amounts of IL-1α,
IL-4, IL-8/CXCL8, GRO-α, GRO-β and GRO-γ than did
those freed from polystyrene-stuck HDFs.
IL-1α and IL-1β belong to the IL-1 cytokine family,
whose signalling plays a prominent role in the regulation
of angiogenesis and vascular permeability [82]. It is well
known that IL-1α can mediate angiogenesis in cancers,
the brain and the healing of wounds in which IL-1α and
IL-1β act synergistically [83]. IL-1α activates fibroblasts and
drives FGF-7 secretion, thus indirectly promoting wound re-
epithelization [84]. This stimulation of dermal fibroblasts by
IL-1α optimally enhances epidermal stem cell proliferation
thereby promoting wound healing and hair regrowth [85].
T helper 2 lymphocytes, mast cells, eosinophils, basophils
and (in lesser amounts) fibroblasts typically secrete IL-4,
a beneficial anti-inflammatory cytokine. IL-4 hinders the
production and secretion of pro-inflammatory cytokines,
chemokines, proteases, and reactive oxygen species [86].
Moreover, a controlled release of IL-4 favourably promotes
polarization of macrophages from the M1 phenotype,
which helps chronicize wounds, to the M2 phenotype,
which is beneficial to wound healing [87]. Adding IL-4 to
monocytes/macrophages co-cultured with ECs led to a more
abundant sprout-like organization of the ECs within the
hydrogel [88]. Then again, IL-4 acts both as a proangiogenic
and a “fibroblastogenic” cytokine that promotes vessel
sprouting, fibroblast proliferation, and fibroblast synthesis
of ECM proteins, such as collagen and fibronectin, in normal
wound healing [89].
IL-8/CXCL8 is a member of the CXC family and acts
as a pro-angiogenic chemokine as it incorporates the Glu-
Leu-Arg sequence (the so called ELR motif). The latter
allows the formation of IL-8/CXCL8·CXCR2 (C-X-C Motif
Chemokine Receptor 2) complexes, thereby inducing a strong
angiogenic activity in ECs [90, 91]. The 3 CXCR2 ligands,
IL-8/CXCL8, GRO-α and ENA78, have become known as
promoters of angiogenesis in tumours [92] and idiopathic
pulmonary fibrosis [93, 94]. Together with GRO-α/CXCL1,
IL-8/CXCL8 promotes angiogenesis in the sub-epithelial cell
layer of the airways [95]. Conversely, IL-8/CXCL8 acts as an
anti-angiogenic chemokine when it interacts with the atypical
Duffy antigen/chemokine receptor ECs also express [96, 97].
Moreover, by binding the CXCR1 receptor, IL-8/CXCL8
attracts leukocytes to places of inflammation [98]. Besides,
metastasis-associated fibroblasts stimulated angiogenesis
through the secretion of IL-8/CXCL8 and MCP-1/CCL2
[99]. Interestingly, VEGF and IL-8/CXCL8 co-operated to
increase the recruitment of EPCs in skin keloids [100]. Finally,
according to mounting evidence, the interaction of adipose-
derived stem cells with microvascular ECs promoted angio-
genesis by modulating the levels of IL-8/CXCL8, IL-6,MCP-1
and VEGF, thus advancing the healing of chronic soft tissue
wounds [101].
Human chemokines GRO-α/CXCL1, GRO-β/CXCL2
and GRO-γ /CXCL3 are products of 3 distinct, non-allelic
genes. GRO-β and GRO-γ share a 90% and 86% amino
acid sequence homology, respectively, with GRO-α. They
are members of the CXC family endowed with an ELR
motif and, when they interact with the CXCR2 receptor,
promote EC proliferation and migration, angiogenesis and
neovascularization even in the absence of a concurrent tissue
inflammation [91]. Normal human epidermis expresses
GRO-α/CXCL1 and GRO-β/CXCR2, which are especially
involved in the healing of human burn wounds [102].
GRO-α/CXCL1 attracts neutrophils, is upregulated in
acute wounds and, by promoting keratinocyte migration,
advances wound reepithelization [76, 103]. In addition,
GRO-α/CXCL1 is one of the chemokines endowed with
liver regenerative powers [104] and, as just mentioned,
acting together with IL-8/CXCL8, promotes angiogenesis
in the sub-epithelial cell layer of airways [95] and in cases
of Sjögren’s syndrome [105]. Heightened, as compared to
controls, serum levels of GRO-α/CXCL1 were taken as
markers of angiogenesis and inflammation in patients with
type 2 diabetes [106]. GRO-β/CXCL2 chemokine is of
importance for the correct breaching of EC junctions [107].
Finally, scleroderma microvascular ECs are unresponsive to
GRO-γ /CXCL3·CXCR2 signalling [108].
Conclusions
The present results show that HDFs grown on a novel kind
of 3D-SFnws release exosomes that hold significant amounts
of several cytokines, chemokines and other factors, some of
which mainly advance angiogenesis (i.e. ANGPT-1, ANGPT-
2, Tie-2), some both angiogenesis and mitogenesis (i.e. IL-1α,
IL-4, IL-8, GRO-α, GRO-β and GRO-γ ) and a few of which
are more involved in ECM’s proangiogenic remodelling (i.e.
MMP-1, TIMP-1, uPAR). The amounts of said factors were
significantly higher in the exosomes released from 3D-SFnws-
adhering HDFs than in those released from polystyrene-stuck
monolayered HDFs. These results suggest that the exosomal
over-release of angiogenic and trophic factors from the SF-
adhering HDFs did promote, once grafted into the skin
subcutaneous tissue of living mice, the early-onset, quick and
abundant vascularization and cellular colonization of the pre-
viously studied 2 types of 3D-SFnws. The same results prove
that the exosomes released from 3D-SFnws-adhering HDFs
exert a powerful proangiogenic stimulus on HDMVECs.
These crucial consequences of the interactions between SF
microfibers and non-tumorigenic HDFs and HDMVECs are
well worth further studies related to the application of 3D SF-
based nonwoven grafts in human (and even veterinary) clini-
cal settings for the guided engineering, neovascularization and
regeneration of substantial skin losses due to burns, diabetic
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